Statin use linked with better outcomes in patients starting ADT for prostate cancer

“We continue to see a building story of benefit of statin medications in men who have prostate cancer,” says Robert J. Hamilton, MD, MPH.

In this interview, Robert J. Hamilton, MD, MPH, discusses findings from a recent study published in European Urology titled, “The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy,” for which he served as a study author. Hamilton is an associate professor of urology at the University of Toronto.

More videos:

Clinical care pathway demonstrates efficacy for patients with overactive bladder

Analysis underscores importance of pretreatment urine cultures in patients with recurrent UTI

A primer for urologists on statutes of limitations